These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25880614)

  • 61. Development of synthetic peptide-modified liposomes with LDL receptor targeting capacity and improved anticancer activity.
    Liu M; Li W; Larregieu CA; Cheng M; Yan B; Chu T; Li H; Mao SJ
    Mol Pharm; 2014 Jul; 11(7):2305-12. PubMed ID: 24830852
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liposomal doxorubicin doubly functionalized with CCK8 and R8 peptide sequences for selective intracellular drug delivery.
    Ringhieri P; Diaferia C; Galdiero S; Palumbo R; Morelli G; Accardo A
    J Pept Sci; 2015 May; 21(5):415-25. PubMed ID: 25754969
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
    Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
    Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis.
    Yu-Wai-Man C; Tagalakis AD; Manunta MD; Hart SL; Khaw PT
    Sci Rep; 2016 Feb; 6():21881. PubMed ID: 26905457
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages.
    Nogueira E; Freitas J; Loureiro A; Nogueira P; Gomes AC; Preto A; Carmo AM; Moreira A; Cavaco-Paulo A
    Colloids Surf B Biointerfaces; 2017 Jul; 155():459-465. PubMed ID: 28472749
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Determination of the activity of maleimide-functionalized phospholipids during preparation of liposomes.
    Oswald M; Geissler S; Goepferich A
    Int J Pharm; 2016 Nov; 514(1):93-102. PubMed ID: 27863688
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Doping hydroxylated cationic lipid into PEGylated cerasome boosts in vivo siRNA transfection efficacy.
    Li Y; Zheng S; Liang X; Jin Y; Wu Y; Bai H; Liu R; Dai Z; Liang Z; Shi T
    Bioconjug Chem; 2014 Nov; 25(11):2055-66. PubMed ID: 25260060
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Self-assembling peptide-based nanoparticles for siRNA delivery in primary cell lines.
    Deshayes S; Konate K; Rydström A; Crombez L; Godefroy C; Milhiet PE; Thomas A; Brasseur R; Aldrian G; Heitz F; Muñoz-Morris MA; Devoisselle JM; Divita G
    Small; 2012 Jul; 8(14):2184-8. PubMed ID: 22514050
    [No Abstract]   [Full Text] [Related]  

  • 70. Folic acid and cell-penetrating peptide conjugated PLGA-PEG bifunctional nanoparticles for vincristine sulfate delivery.
    Chen J; Li S; Shen Q
    Eur J Pharm Sci; 2012 Sep; 47(2):430-43. PubMed ID: 22796217
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dual targeted polymeric nanoparticles based on tumor endothelium and tumor cells for enhanced antitumor drug delivery.
    Gupta M; Chashoo G; Sharma PR; Saxena AK; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2014 Mar; 11(3):697-715. PubMed ID: 24512060
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A novel gemcitabine derivative-loaded liposome with great pancreas-targeting ability.
    Li PW; Luo S; Xiao LY; Tian BL; Wang L; Zhang ZR; Zeng YC
    Acta Pharmacol Sin; 2019 Nov; 40(11):1448-1456. PubMed ID: 31015736
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Folic acid-tethered Pep-1 peptide-conjugated liposomal nanocarrier for enhanced intracellular drug delivery to cancer cells: conformational characterization and in vitro cellular uptake evaluation.
    Kang MJ; Park SH; Kang MH; Park MJ; Choi YW
    Int J Nanomedicine; 2013; 8():1155-65. PubMed ID: 23515421
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CXCR4-targeted modular peptide carriers for efficient anti-VEGF siRNA delivery.
    Egorova A; Shubina A; Sokolov D; Selkov S; Baranov V; Kiselev A
    Int J Pharm; 2016 Dec; 515(1-2):431-440. PubMed ID: 27789364
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells.
    Gomes-da-Silva LC; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):356-64. PubMed ID: 23659854
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy.
    Qian J; Xu M; Suo A; Xu W; Liu T; Liu X; Yao Y; Wang H
    Acta Biomater; 2015 Mar; 15():102-16. PubMed ID: 25545322
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Failure of active targeting by a cholesterol-anchored ligand and improvement by altering the lipid composition to prevent ligand desorption.
    Yamamoto S; Sakurai Y; Harashima H
    Int J Pharm; 2018 Jan; 536(1):42-49. PubMed ID: 29126905
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cell-specific siRNA delivery by peptides and antibodies.
    Lee SK; Siefert A; Beloor J; Fahmy TM; Kumar P
    Methods Enzymol; 2012; 502():91-122. PubMed ID: 22208983
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
    Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
    AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
    Spagnou S; Miller AD; Keller M
    Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.